n-3 Fatty adds do not prevent restenosis after coronary angioplasty: Results from the CART study

Journal of the American College of Cardiology

Volumn 33, Issue 6, 1999, Pages 1619-1626

  Johansen, Odd ^a   Brekke, Magne ^a   Seljeflot, Ingebjørg ^a   Abdelnoor, Michael ^a   Arnesen, Harald ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORN OIL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; PREMEDICATION; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT FAILURE;

EID: 0033133488     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00054-6     Document Type: Article

References (36)

1. Gruentzig A. Transluminal dilatation of coronary-artery stenosis (letter). Lancet. 1:1978;263.
2. Landau C., Lange R.A., Hillis L.D. Percutaneous transluminal coronary angioplasty. N Engl J Med. 330:1994;981-993.
3. Cairns J.A., Gill J., Morton B., et al. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR study. Circulation. 94:1996;1553-1560.
4. Leaf A., Jorgensen M.B., Jacobs A.K., et al. Do fish oils prevent restenosis after coronary angioplasty? Circulation. 90:1994;2248-2257.
5. Lange R.A., Willard J.E., Hillis L.D. South-western internal medicine conference restenosis: the Achilles heel of coronary angioplasty . Am J Med Sci. 306:1993;265-275.
6. Libby P., Schwartz D., Brogi E., et al. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 86:(Suppl):1992;III47-III52.
7. Majesky M.W. Neointima formation after acute vascular injury. Role of counteradhesive extracellular matrix proteins. Tex Heart Inst J. 21:1994;78-85.
8. Hamon M., Bauters C., McFadded E.P., et al. Restenosis after coronary angioplasty. Eur Heart J. 16:(Suppl I):1995;33-48.
9. Schwartz R.S. Pathophysiology of restenosis interaction of thrombosis, hyperplasia, and/or remodeling . Am J Cardiol. 81:1998;14E-17E.
10. Tardif J.C., Cote G., Lesperance J., et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med. 337:1997;365-372.
11. Fox P.L., DiCorleto P.E. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science. 241:1988;453-456.
12. Leaf A., Webster M.B. Cardiovascular effects of n-3 fatty acids. N Engl J Med. 318:1988;549-557.
13. Fanelli C., Aronoff R. Restenosis following coronary angioplasty. Am Heart J. 119:1990;357-368.
14. Blackshear J.L., O'Callaghan W.G., Califf R.M. Medical approaches to prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 9:1987;834-848.
15. Hermans W.R., Rensing B.J., Strauss B.H., Serruys P.W. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet." Am Heart J. 122:1991;171-187.
16. Eritsland J., Arnesen H., Gronseth K., et al. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 77:1996;31-36.
17. Dehmer G.J., Popma J.J., van den Berg E.K., et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 319:1988;733-740.
18. Bairati I., Roy L., Meyer F. Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 85:1992;950-956.
19. Grigg L.E., Kay T.W., Valentine P.A., et al. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol. 13:1989;665-672.
20. Kaul U., Sanghvi S., Bahl V.K., et al. Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol. 35:1992;87-93.
21. Milner M.R., Gallino R.A., Leffingwell A., et al. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 64:1989;294-299.
22. Nye E.R., Ablett M.B., Robertson M.C., et al. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med. 20:1990;549-552.
23. Reis G.J., Boucher T.M., Sipperly M.E., et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 2:1989;177-181.
24. Bellamy C.M., Schofield P.M., Faragher E.B., Ramsdale D.R. Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate? Eur Heart J. 13:1992;1626-1631.
25. Franzen D., Schannwell M., Oette K., Hopp H.W. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. Cathet Cardiovasc Diagn. 28:1993;301-310.
26. O'Connor G.T., Malenka D.J., Olmstead E.M., et al. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med. 8:1992;186-192.
27. Gapinski J.P., VanRuiswyk J.V., Heudebert G.R., Schectman G.S. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med. 153:1993;1595-1601.
28. Nes M., Frost Andersen L., Solvoll K., et al. Accuracy of a quantitative food frequency questionnaire applied in elderly Norwegian women. Eur J Clin Nutr. 46:1992;809-821.
29. Bertrand M.E., McFadden E.P., Fruchart J.C., et al. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. J Am Coll Cardiol. 30:1997;863-869.
30. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
31. Bouyer J. La regression logistique en epidemiologie. Rev Epidem Santa, Publ. 39:1991;79-87.
32. Anonymous. Center for Disease Control Epidemiology Program Office, ed. Epi Info. Version 5.01a. 1991.
33. Weintraub W.S., Boccuzzi S.J., Klein J.L., et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med. 331:1994;1331-1337.
34. Beatt K.J., Serruys P.W., Hugenholtz P.G. Restenosis after coronary angioplasty new standards for clinical studies . J Am Coll Cardiol. 15:1990;491-498.
35. Pickering J.G., Ford C.M., Chow L.H. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions. Am J Cardiol. 78:1996;633-637.
36. LeLorier J., Gregoire G., Benhaddad A., et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 337:1997;536-542.